Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,253 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $625.06 | 10 | $0 (2024) |
| Lilly USA, LLC | $184.46 | 6 | $0 (2024) |
| Amgen Inc. | $145.89 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $99.17 | 2 | $0 (2023) |
| Scilex Pharmaceuticals Inc. | $65.23 | 1 | $0 (2019) |
| Novo Nordisk Inc | $58.74 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39.16 | 2 | $0 (2024) |
| Emergent BioSolutions Inc. | $20.34 | 1 | $0 (2019) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $507.80 | 11 | AstraZeneca Pharmaceuticals LP ($413.75) |
| 2023 | $538.43 | 14 | AstraZeneca Pharmaceuticals LP ($211.31) |
| 2021 | $121.55 | 1 | Amgen Inc. ($121.55) |
| 2019 | $85.57 | 2 | Scilex Pharmaceuticals Inc. ($65.23) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $116.43 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $106.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Inflammation | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: Respiratory | ||||||
| 10/20/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 10/10/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $74.61 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 08/29/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 08/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 08/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Diabetes | ||||||
| 06/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Diabetes | ||||||
| 05/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $98.42 | General |
| Category: Diabetes | ||||||
| 01/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.00 | General |
| Category: Respiratory | ||||||
| 01/11/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA | Food and Beverage | In-kind items and services | $54.99 | General |
| Category: Respiratory | ||||||
About Dr. Yarima Marcucci Ramos, MD
Dr. Yarima Marcucci Ramos, MD is a General Practice healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427151356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yarima Marcucci Ramos, MD has received a total of $1,253 in payments from pharmaceutical and medical device companies, with $507.80 received in 2024. These payments were reported across 28 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,253).
Practice Information
- Specialty General Practice
- Other Specialties General Practice, General Practice
- Location Clermont, FL
- Active Since 09/06/2006
- Last Updated 11/03/2025
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1427151356
Products in Payments
- AIRSUPRA (Drug) $262.12
- BREZTRI (Drug) $210.77
- FARXIGA (Drug) $152.17
- Otezla (Drug) $145.89
- MOUNJARO (Drug) $117.46
- JARDIANCE (Drug) $106.16
- AREXVY (Drug) $99.17
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $65.23
- Ozempic (Drug) $39.46
- Narcan (Drug) $20.34
- Rybelsus (Drug) $19.28
- CAPLYTA (Drug) $15.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Clermont
Fadi Rahhal, Md, MD
General Practice — Payments: $11,386
Egle Skruodyte, Dmd, DMD
General Practice — Payments: $6,308
Dr. Edwin Acosta, Dds, DDS
General Practice — Payments: $6,063
Dr. Carlos Ortiz, D.d.s, D.D.S
General Practice — Payments: $3,626
Nanette Ortiz, Md, MD
General Practice — Payments: $2,828
Dr. Freddy Mezquia, Dmd, DMD
General Practice — Payments: $2,632